It’s getting harder for scientists to collaborate across borders – that’s bad when the world faces global problems like pandemics and climate change
Scientific research done through international collaboration has boomed in the past 30 years. But recently, powerful countries are using science as a tool…
The United Nations and many researchers have emphasized the critical role international collaborative science plays in solving global challenges like climate change, biodiversity loss and pandemics. The rise of non-Western countries as science powers is helping to drive this type of global cooperative research. For example, Brazil, Russia, India, China and South Africa formed a tuberculosis research network in 2017 and are making significant advancements on basic and applied research into the disease.
The near-global cessation of collaboration with Russian scholars following the invasion of Ukraine – in everything from humanities research to climate science in the Arctic – is one example of science being a victim of – and used as a tool for – international politics. Scientific collaboration between China and the U.S. is also breaking down in fields like microelectronics and quantum computing because of national security concerns on both sides.
I am a policy expert who studies international research collaboration as it relates to global problems and geopolitical polarization. I understand the need for democratic countries to respond to the the growing strength of authoritarian countries such as China and acute crises like the Russian invasion of Ukraine. But reducing or stopping international research comes with its own risks. It slows down the production of knowledge needed to address long-term global problems and reduces the potential for future scientific collaboration.
Growth of non-Western science
Since the 1990s and the collapse of the Soviet Union, global collaboration in science has increased dramatically. There are several reasons for this development.
First, the collapse of the Soviet Union in 1991 led to an increased openness in global scientific exchange. In particular, there was growth in the number of students from developing and non-Western countries going to universities in the West. This movement formed networks of researchers from many countries. Second, massively collaborative scientific efforts – such as the Human Genome Project – as well as the ever-growing importance of expensive, large research laboratories and instruments have fueled international collaboration. Finally, the digital revolution has made it much easier to communicate and share data across borders. This all resulted in collaborative and fruitful research in many fields including gene technology, climate science and artificial intelligence.
In the latter half of the 20th century, China, India, Russia, Turkey, Iran, Egypt, Saudi Arabia and many other nations all significantly improved their scientific capabilities. In doing so they have greatly contributed to human knowledge. China in particular has invested heavily in its scientific capabilities and today is the world’s largest producer of scientific publications.
The development of scientific capacity in many parts of the world and the building of academic ties is critical when it comes to responding to a new virus or tracking changes in climate. The more countries that share data and coordinate policy responses, the easier it should be to contain a virus or understand global warming.
Western concern of a rising China
Generally speaking, there are three global superpowers competing for scientific and technological leadership today: the U.S., China and the European Union.
Both the U.S. and Europe have taken steps to slow down China’s scientific rise, and these efforts have dampened research collaboration.AP Photo/Charles Dharapak
In May 2022, U.S. Secretary of State Antony Blinken said: “China is the only country with both the intent to reshape the international order and, increasingly, the economic, diplomatic, military, and technological power to do it. Beijing’s vision would move us away from the universal values that have sustained so much of the world’s progress over the past 75 years.”
China’s rise in science and technology has been met with stern responses from the West. Australia passed legislation in 2020 that gave the federal government veto power over foreign agreements in research. In the U.S., the Export Control Reform Act of 2018 was designed to reduce dependence on China for emerging and foundational technologies.
Shortly after Russia’s invasion of Ukraine and subsequent Western-imposed sanctions, Russia threatened to pull out of the International Space Station.NASA/Flickr
Science as a tool of politics
Given this framing of research as a part of international competition between China and the West, it is not surprising that science is increasingly being used as a political tool.
The U.S. government has taken significant steps to try to limit China’s scientific progress and international influence. In 2018, the U.S. launched a large-scale anti-espionage effort called the China Initiative. Under this initiative, the FBI broadly investigated U.S.-Chinese links within the corporate and academic sectors. The China Initiative failed to find any Chinese spies. But three U.S.-based scholars were convicted for failing to disclose Chinese ties.
The European Union has taken a similar stance. It calls China simultaneously a partner, competitor and systemic rival. The EU has outlined goals of increasing European scientific and technological autonomy to reduce reliance on other countries, especially China, and started to implement the strategy in 2021.
China is also using science, technology and scholarly research generally to serve national interests. The government has explicitly pushed the idea that research shall primarily serve national needs, and Chinese scholars are increasingly under political control. In 2021 there were 18 research centers devoted to studying and promoting Xi Jinping’s ideas on matters such as rule of law, economics and green development.
Global consequences
Many researchers in the U.S., Europe and China have voiced concerns that geopolitical rivalries are curtailing international research collaboration at a time when the world needs it the most.
There is a major risk that the impediments to international scientific collaboration will further increase, further harming data sharing, the quality of research and the ability to disseminate results that contributing to solving problems. I often hear researchers, university leaders and funding agencies in Europe, the U.S. and China vent their frustration with the current situation. Many in the research community would like to see a more open and global science landscape.
It is possible to work toward a future where science is more separate – but not naively isolated – from changing power dynamics. As issues like climate change increase in severity, it will become only more important that researchers build international relationships that are responsible, reciprocal, transparent and equitable.
Tommy Shih is a consultant to the Swedish Foundation for International Cooperation in Research and Higher Education.
Watch Yield Curve For When Stocks Begin To Price Recession Risk
Authored by Simon White, Bloomberg macro strategist,
US large-cap indices are currently diverging from recessionary leading economic data. However, a decisive steepening in the yield curve leaves growth stocks and therefore the overall index facing lower prices.
Leading economic data has been signalling a recession for several months. Typically stocks closely follow the ratio between leading and coincident economic data.
As the chart below shows, equities have recently emphatically diverged from the ratio, indicating they are supremely indifferent to very high US recession risk.
What gives? Much of the recent outperformance of the S&P has been driven by a tiny number of tech stocks. The top five S&P stocks’ mean return this year is over 60% versus 0% for the average return of the remaining 498 stocks.
The belief that generative AI is imminently about to radically change the economy and that Nvidia especially is positioned to benefit from this has been behind much of this narrow leadership.
Regardless on your views whether this is overdone or not, it has re-established growth’s dominance over value. Energy had been spearheading the value trade up until around March, but since then tech –- the vessel for many of the largest growth stocks –- has been leading the S&P higher.
The yield curve’s behaviour will be key to watch for a reversion of this trend, and therefore a heightened risk of S&P 500 underperformance. Growth stocks tend to outperform value stocks when the curve flattens. This is because growth companies often have a relative advantage over typically smaller value firms by being able to borrow for longer terms. And vice-versa when the curve steepens, growth firms lose this relative advantage and tend to underperform.
The chart below shows the relationship, which was disrupted through the pandemic. Nonetheless, if it re-establishes itself then the curve beginning to durably re-steepen would be a sign growth stocks will start to underperform again, taking the index lower in the process.
Equivalently, a re-acceleration in US inflation (whose timing depends on China’s halting recovery) is more likely to put steepening pressure on the curve as the Fed has to balance economic growth more with inflation risks. Given the growth segment’s outperformance is an indication of the market’s intensely relaxed attitude to inflation, its resurgence would be a high risk for sending growth stocks lower.
COVID-19 lockdowns linked to less accurate recollection of event timing
Participants in a survey study made a relatively high number of errors when asked to recollect the timing of major events that took place in 2021, providing…
Participants in a survey study made a relatively high number of errors when asked to recollect the timing of major events that took place in 2021, providing new insights into how COVID-19 lockdowns impacted perception of time. Daria Pawlak and Arash Sahraie of the University of Aberdeen, UK, present these findings in the open-access journal PLOS ONE on May 31, 2023.
Participants in a survey study made a relatively high number of errors when asked to recollect the timing of major events that took place in 2021, providing new insights into how COVID-19 lockdowns impacted perception of time. Daria Pawlak and Arash Sahraie of the University of Aberdeen, UK, present these findings in the open-access journal PLOS ONE on May 31, 2023.
Remembering when past events occurred becomes more difficult as more time passes. In addition, people’s activities and emotions can influence their perception of the passage of time. The social isolation resulting from COVID-19 lockdowns significantly impacted people’s activities and emotions, and prior research has shown that the pandemic triggered distortions in people’s perception of time.
Inspired by that earlier research and clinical reports that patients have become less able to report accurate timelines of their medical conditions, Pawlak and Sahraie set out to deepen understanding of the pandemic’s impact on time perception.
In May 2022, the researchers conducted an online survey in which they asked 277 participants to give the year in which several notable recent events occurred, such as when Brexit was finalized or when Meghan Markle joined the British royal family. Participants also completed standard evaluations for factors related to mental health, including levels of boredom, depression, and resilience.
As expected, participants’ recollection of events that occurred further in the past was less accurate. However, their perception of the timing of events that occurred in 2021—one year prior to the survey—was just an inaccurate as for events that occurred three to four years earlier. In other words, many participants had difficulty recalling the timing of events coinciding with COVID-19 lockdowns.
Additionally, participants who made more errors in event timing were also more likely to show greater levels of depression, anxiety, and physical mental demands during the pandemic, but had less resilience. Boredom was not significantly associated with timeline accuracy.
These findings are similar to those previously reported for prison inmates. The authors suggest that accurate recollection of event timing requires “anchoring” life events, such as birthday celebrations and vacations, which were lacking during COVID-19 lockdowns.
The authors add: “Our paper reports on altered timescapes during the pandemic. In a landscape, if features are not clearly discernible, it is harder to place objects/yourself in relation to other features. Restrictions imposed during the pandemic have impoverished our timescape, affecting the perception of event timelines. We can recall that events happened, we just don’t remember when.
#####
In your coverage please use this URL to provide access to the freely available article in PLOS ONE: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0278250
Citation: Pawlak DA, Sahraie A (2023) Lost time: Perception of events timeline affected by the COVID pandemic. PLoS ONE 18(5): e0278250. https://doi.org/10.1371/journal.pone.0278250
Author Countries: UK
Funding: The authors received no specific funding for this work.
Journal
PLoS ONE
DOI
10.1371/journal.pone.0278250
Method of Research
Survey
Subject of Research
Not applicable
Article Title
Lost time: Perception of events timeline affected by the COVID pandemic
Article Publication Date
31-May-2023
COI Statement
The authors have declared that no competing interests exist.
Hyro secures $20M for its AI-powered, healthcare-focused conversational platform
Israel Krush and Rom Cohen first met in an AI course at Cornell Tech, where they bonded over a shared desire to apply AI voice technologies to the healthcare…
Israel Krush and Rom Cohen first met in an AI course at Cornell Tech, where they bonded over a shared desire to apply AI voice technologies to the healthcare sector. Specifically, they sought to automate the routine messages and calls that often lead to administrative burnout, like calls about scheduling, prescription refills and searching through physician directories.
Several years after graduating, Krush and Cohen productized their ideas with Hyro, which uses AI to facilitate text and voice conversations across the web, call centers and apps between healthcare organizations and their clients. Hyro today announced that it raised $20 million in a Series B round led by Liberty Mutual, Macquarie Capital and Black Opal, bringing the startup’s total raised to $35 million.
Krush says that the new cash will be put toward expanding Hyro’s go-to-market teams and R&D.
“When we searched for a domain that would benefit from transforming these technologies most, we discovered and validated that healthcare, with staffing shortages and antiquated processes, had the greatest need and pain points, and have continued to focus on this particular vertical,” Krush told TechCrunch in an email interview.
To Krush’s point, the healthcare industry faces a major staffing shortfall, exacerbated by the logistical complications that arose during the pandemic. In a recent interview with Keona Health, Halee Fischer-Wright, CEO of Medical Group Management Association (MGMA), said that MGMA’s heard that 88% of medical practices have had difficulties recruiting front-of-office staff over the last year. By another estimates, the healthcare field has lost 20% of its workforce.
Hyro doesn’t attempt to replace staffers. But it does inject automation into the equation. The platform is essentially a drop-in replacement for traditional IVR systems, handling calls and texts automatically using conversational AI.
Hyro can answer common questions and handle tasks like booking or rescheduling an appointment, providing engagement and conversion metrics on the backend as it does so.
Plenty of platforms do — or at least claim to. See RedRoute, a voice-based conversational AI startup that delivers an “Alexa-like” customer service experience over the phone. Elsewhere, there’s Omilia, which provides a conversational solution that works on all platforms (e.g. phone, web chat, social networks, SMS and more) and integrates with existing customer support systems.
But Krush claims that Hyro is differentiated. For one, he says, it offers an AI-powered search feature that scrapes up-to-date information from a customer’s website — ostensibly preventing wrong answers to questions (a notorious problem with text-generating AI). Hyro also boasts “smart routing,” which enables it to “intelligently” decide whether to complete a task automatically, send a link to self-serve via SMS or route a request to the right department.
A bot created using Hyro’s development tools. Image Credits: Hyro
“Our AI assistants have been used by tens of millions of patients, automating conversations on various channels,” Krush said. “Hyro creates a feedback loop by identifying missing knowledge gaps, basically mimicking the operations of a call center agent. It also shows within a conversation exactly how the AI assistant deduced the correct response to a patient or customer query, meaning that if incorrect answers were given, an enterprise can understand exactly which piece of content or dataset is labeled incorrectly and fix accordingly.”
Of course, no technology’s perfect, and Hyro’s likely isn’t an exception to the rule. But the startup’s sales pitch was enough to win over dozens of healthcare networks, providers and hospitals as clients, including Weill Cornell Medicine. Annual recurring revenue has doubled since Hyro went to market in 2019, Krush claims.
Hyro’s future plans entail expanding to industries adjacent to healthcare, including real estate and the public sector, as well as rounding out the platform with more customization options, business optimization recommendations and “variety” in the AI skills that Hyro supports.
“The pandemic expedited digital transformation for healthcare and made the problems we’re solving very clear and obvious (e.g. the spike in calls surrounding information, access to testing, etc.),” Krush said. “We were one of the first to offer a COVID-19 virtual assistant that deployed in under 48 hours based on trusted information from the health system and trusted resources such as the CDC and World Health Organization …. Hyro is well funded, with good growth and momentum, and we’ve always managed a responsible budget, so we’re actually looking to expand and gather more market share while competitors are slowing down.”
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.